Atlas Trials

ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation

Clinical trial NCT07015853 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07015853
Sponsor
Stephen Shiao
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
TNBC - Triple-Negative Breast CancerBreast Cancer
Start date
2026-06-01
Primary completion
2033-07-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.